BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26409627)

  • 1. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
    Vishnu A; Gurka MJ; DeBoer MD
    Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
    Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
    Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.
    Gurka MJ; Golden SH; Musani SK; Sims M; Vishnu A; Guo Y; Cardel M; Pearson TA; DeBoer MD
    Diabetologia; 2017 Jul; 60(7):1261-1270. PubMed ID: 28378033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms are associated with worsened severity of the metabolic syndrome in African American women independent of lifestyle factors: A consideration of mechanistic links from the Jackson heart study.
    Gurka MJ; Vishnu A; Okereke OI; Musani S; Sims M; DeBoer MD
    Psychoneuroendocrinology; 2016 Jun; 68():82-90. PubMed ID: 26963374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.
    DeBoer MD; Filipp SL; Sims M; Musani SK; Gurka MJ
    Stroke; 2020 Aug; 51(8):2548-2552. PubMed ID: 32552367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
    DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
    Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
    Gurka MJ; Filipp SL; Pearson TA; DeBoer MD
    J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study.
    DeBoer MD; Gurka MJ; Woo JG; Morrison JA
    Diabetologia; 2015 Dec; 58(12):2745-52. PubMed ID: 26380985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Metabolic Syndrome Severity During the Menopausal Transition.
    Gurka MJ; Vishnu A; Santen RJ; DeBoer MD
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27487829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium.
    Koskinen J; Magnussen CG; Sinaiko A; Woo J; Urbina E; Jacobs DR; Steinberger J; Prineas R; Sabin MA; Burns T; Berenson G; Bazzano L; Venn A; Viikari JSA; Hutri-Kähönen N; Raitakari O; Dwyer T; Juonala M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome positively correlates with the risks of atherosclerosis and diabetes in a Chinese population.
    Tsai SS; Lin YS; Chen ST; Chu PH
    Eur J Intern Med; 2018 Aug; 54():40-45. PubMed ID: 29655805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective and subjective socioeconomic status associated with metabolic syndrome severity among African American adults in Jackson Heart Study.
    Cardel MI; Guo Y; Sims M; Dulin A; Miller D; Chi X; Pavela G; DeBoer MD; Gurka MJ
    Psychoneuroendocrinology; 2020 Jul; 117():104686. PubMed ID: 32361636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors.
    Walker SE; Gurka MJ; Oliver MN; Johns DW; DeBoer MD
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):141-8. PubMed ID: 20708390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.
    Magnussen CG; Koskinen J; Chen W; Thomson R; Schmidt MD; Srinivasan SR; Kivimäki M; Mattsson N; Kähönen M; Laitinen T; Taittonen L; Rönnemaa T; Viikari JS; Berenson GS; Juonala M; Raitakari OT
    Circulation; 2010 Oct; 122(16):1604-11. PubMed ID: 20921439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis.
    Lin SX; Carnethon M; Szklo M; Bertoni A
    Metab Syndr Relat Disord; 2011 Feb; 9(1):35-40. PubMed ID: 20958206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
    Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
    Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.